多替阿巴拉米片在哪里能够买到?
(Alias: dolutegravir tablets) is currently the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of good tolerance, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.
The main ingredient of Doptabalamid Tablets (Suimeikai) is Doptabalamid. This product is a film-coated tablet that appears white or off-white after the coating is removed. This product should be taken under the guidance of a physician with experience in HIV infection. This product can be taken with or without food.
According to Medical Companion Travel, the price of Suimeikan (Abalamid Tablets, Inbec) available in China is relatively expensive, and most patients cannot afford it. The domestic price of Suimeike (Abalamid Tablets, Inbec) in China is 2,880$/month. Patients who cannot afford domestic Suimeike (Dolutea, Inbec) can choose to buy Suimeike (Dolutea, Inbec) which is available in India, and the price is relatively cheap. Suimeike (Abalamid Tablets, Inbec) produced by the Indian company Emcure, comes in a box of 30 tablets, priced at approximately RMB 1,000.
Where can I buy it? Currently, patients who want to buy Dolutegra Abalamid Tablets can buy them at home, but domestic drugs are relatively expensive. Patients can also choose to go abroad to buy the Indian version of Dolutegra Abalamid Tablets, which is more affordable. Some patients who cannot go abroad can find a professional overseas medical service agency (such as Medical Companion Travel Service) in China. They can arrange for a dedicated person to accompany the patient to a large hospital in India for expert diagnosis and treatment. After the diagnosis and treatment, the medicine is returned directly from the Indian hospital. The medicine is safe and reliable. For details, please contact Medical Companion Travel Service.
Recommended related hot articles: /newsDetail/77247.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)